NMD Pharma is currently owned by Jeito Capital, through Jeito I, since 2022.

When did Jeito Capital acquire NMD Pharma?

Jeito Capital acquired NMD Pharma in 2022 (active for 4 years).

Home/Companies/Biotech/NMD Pharma

NMD Pharma

Biotech·

Denmark·Active·4yr hold

NMD Pharma is a healthcare company, headquartered in France.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

Jeito Capital

Key facts

HQFrance

SectorHealthcare

Aarhus-based biotech developing first-in-class therapies for neuromuscular diseases including myasthenia gravis; Jeito Capital backed in…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito I

Other portfolio companies in the same fund.

Corteria Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings